Drug design and development are costly and lengthy. Mathematical and computational modelling anchored in model-informed drug development (MIDD) and quantitative systems pharmacology (QSP) methodologies are integral to accelerating the R&D pipeline. In parallel, MIDD and QSP can be used to better understand the biological basis of drug responses and fuel new biomedical research paths. This workshop will bring together experts in the fields of MIDD and QSP with the goal of strengthening ties between industrial and academic researchers and advancing these exciting fields.